Your browser doesn't support javascript.
loading
Research progress of decorin gene in oncology / 实用肿瘤学杂志
Practical Oncology Journal ; (6): 44-47, 2016.
Article в Zh | WPRIM | ID: wpr-499325
Ответственная библиотека: WPRO
ABSTRACT
Decorin( DCN) is one of the leucine-rich proteoglycan family of small molecules.It is recog-nized as a tumor suppressor gene.DCN can inhibit tumor cell proliferation and metastasis by binding and inactiva-tion of transforming growth factor beta( TGF-β) and inhibiting the expression of vascular endothelial growth fac-tor or by activating the signaling pathway that promotes cell proliferation by EGFR/MAPK/p21.it plays an impor-tant effect on tumor development,angiogenesis and metastasis.DCN is expressed in various malignant tumors,By up or down regulation,DCN can exert its anti tumor activity,as well as reducing or delaying the occurrence and development of many kinds of malignant tumor.DCN gene may be a potential target for the treatment of many kinds of malignant tumors.
Key words
Полный текст: 1 База данных: WPRIM Язык: Zh Журнал: Practical Oncology Journal Год: 2016 Тип: Article
Полный текст: 1 База данных: WPRIM Язык: Zh Журнал: Practical Oncology Journal Год: 2016 Тип: Article